Phase 1 Study of CC-486 in Japanese Subjects With Hematological Neoplasms
Clinical trial NCT01908387 · TERMINATED
Trial details
- NCT number
- NCT01908387
- Sponsor
- Celgene Corporation
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-01
- Primary completion
- 2015-07-01
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.